Christopher E. Goldring
Impact in
- Pharmacology top 0.05%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Hepatology top 0.5%
- Liver physiology and pathology
Papers in
-
- Genomics, phytochemicals, and oxidative stress 29
- Glutathione Transferases and Polymorphisms 17
- Pluripotent Stem Cells Research 10
- Pharmacology 33
- Drug-Induced Hepatotoxicity and Protection 26
- Pharmacogenetics and Drug Metabolism 16
- Co-authors
- Neil R. Kitteringham (43 shared papers)B. Kevin Park (7 shared papers)Ian M. Copple (23 shared papers)Rosalind E. Jenkins (19 shared papers)B. Kevin Park (18 shared papers)B. Kevin Park (15 shared papers)Daniel J. Antoine (11 shared papers)Joanne Walsh (10 shared papers)
- Journals
- Hepatology (9 papers)Toxicological Sciences (5 papers)Archives of Toxicology (5 papers)British Journal of Clinical Pharmacology (5 papers)Journal of Biological Chemistry (5 papers)
- Partner nations
- United KingdomSwitzerlandUnited States
In The Last Decade
Christopher E. Goldring
123 papers receiving 7.1k citations
Christopher E. Goldring's Hit Papers
Peers
Comparison fields: 5 of 138
- Pharmacology 1.5k
- Hepatology 991
- Cancer Research 738
- Molecular Biology 3.5k
- Oncology 669
Countries citing papers authored by Christopher E. Goldring
This map shows the geographic impact of Christopher E. Goldring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher E. Goldring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher E. Goldring more than expected).
Fields of papers citing papers by Christopher E. Goldring
This network shows the impact of papers produced by Christopher E. Goldring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher E. Goldring. The network helps show where Christopher E. Goldring may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher E. Goldring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation Hit paper breakdown → | 2012 | 878 |
| 2 | Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease Hit paper breakdown → | 2016 | 531 |
| 3 | Circulating microRNAs as potential markers of human drug-induced liver injury Hit paper breakdown → | 2011 | 412 |
| 4 | Managing the challenge of chemically reactive metabolites in drug development Hit paper breakdown → | 2011 | 342 |
| 5 | Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospital Hit paper breakdown → | 2013 | 331 |
| 6 | 2007 | 287 | |
| 7 | 2010 | 228 | |
| 8 | 2011 | 207 | |
| 9 | 2014 | 178 | |
| 10 | 2011 | 177 | |
| 11 | 2004 | 170 | |
| 12 | 2012 | 167 | |
| 13 | 2010 | 142 | |
| 14 | 2003 | 127 | |
| 15 | 2008 | 105 | |
| 16 | 2013 | 102 | |
| 17 | 2016 | 97 | |
| 18 | 2016 | 97 | |
| 19 | 2011 | 86 | |
| 20 | 1996 | 84 |
About Christopher E. Goldring
Christopher E. Goldring is a scholar working on Molecular Biology, Pharmacology, Hepatology, Oncology and Surgery, having authored 125 papers that have together received 7.2k indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (29 papers), Drug-Induced Hepatotoxicity and Protection (26 papers), Liver physiology and pathology (19 papers), Glutathione Transferases and Polymorphisms (17 papers), Pharmacogenetics and Drug Metabolism (16 papers), Pluripotent Stem Cells Research (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and 3D Printing in Biomedical Research (8 papers). The work is most often cited by research in Pharmacology (1.5k citations), Hepatology (991 citations), Cancer Research (738 citations), Molecular Biology (3.5k citations) and Oncology (669 citations). Christopher E. Goldring has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Neil R. Kitteringham, B. Kevin Park, Ian M. Copple, Rosalind E. Jenkins, B. Kevin Park, B. Kevin Park, Daniel J. Antoine, Joanne Walsh, James W. Dear and Kevin B. Park. Their work appears in journals such as Hepatology, Toxicological Sciences, Archives of Toxicology, British Journal of Clinical Pharmacology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.